Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC) [Phase 3]
Phase 3 clinical trial evaluating detection of circulating endothelial progenitor cells in non-small cell lung cancer; the study status is c…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO [Phase 2]
Phase 2 trial of dacomitinib in advanced non-small cell lung cancer evaluating prophylactic interventions for dermatologic and gastrointesti…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy and radiation with or without panitumumab in stage IIIA non-small cell lung cancer has completed with …
-
CLINICAL_TRIALS trial_result · 2016-08-15Clinical Trial Update: Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies [Phase 1, Phase 2]
Phase 1/Phase 2 trial results update for alisertib in adults with advanced nonhematological malignancies, including non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy. [Phase 2]
This update reports the completion of a Phase 2 study evaluating Mircera for anemia in patients with non-small cell lung cancer receiving fi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-08-10Clinical Trial Update: An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
An open-label Phase Ib/II trial of BAY 1000394 (roniciclib) in combination with Docetaxel for second- or third-line advanced non-small cell …
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism [Phase 3]
Phase 3 trial update evaluating an EGFR-TKI with chemotherapy in non-small cell lung cancer patients who have both an EGFR mutation and BIM …
-
CLINICAL_TRIALS research · 2016-08-09Clinical Trial Update: Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) [Phase 2]
Phase 2 neoadjuvant platinum-based chemotherapy for resectable non-small cell lung cancer with switch to an alternative chemotherapy regimen…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI Failure
A completed clinical trial evaluated detection of EGFR T790M mutation in circulating tumor DNA from patients with non-small cell lung cancer…
-
CLINICAL_TRIALS research · 2016-08-05Clinical Trial Update: Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC) [Phase 1]
A Phase 1 trial evaluating an RNActive-derived cancer vaccine with local radiation for stage IV non-small cell lung cancer has been terminat…
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: Apatinib Combined With Docetaxel Monotherapy as Second-line Therapy of Advanced EGFR WT, Non-squamous NSCLC
This clinical trial update reports the evaluation of apatinib combined with docetaxel as a second-line treatment for advanced EGFR wild-type…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: A Study of Erlotinib (Tarceva) in Participants With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 study of Erlotinib (Tarceva) in participants with non-small cell lung cancer has completed, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population [Phase 3]
A Phase 3 trial of a cancer vaccine for Asian patients with stage III unresectable non-small cell lung cancer was terminated, and the result…
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of talactoferrin in patients with relapsed or refractory non-small cell lung cancer or…
-
CLINICAL_TRIALS research · 2016-08-02Clinical Trial Update: Palliative Care Teaching Sessions for Family Caregivers of Patients With Non-Small Cell Lung Cancer [NA]
Clinical trial evaluating palliative care teaching sessions for family caregivers of patients with non-small cell lung cancer has completed.…
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC [Phase 2]
A Phase II study assessing safety and efficacy of crizotinib in East Asian patients with ROS1-positive, ALK-negative advanced non-small cell…
-
CLINICAL_TRIALS withdrawal · 2016-08-01Clinical Trial Update: Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-small-cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating durvalumab with or without bavituximab in previously treated metastatic non-small cell lung cancer has been withd…
-
CLINICAL_TRIALS research · 2016-07-29Clinical Trial Update: Immunotherapy With Racotumomab in Advanced Lung Cancer [Phase 3]
This clinical trial update reports on a Phase 3 study of racotumomab immunotherapy in advanced non-small cell lung cancer, sponsored by Reco…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: A Study to Assess the Survival of Non-small Cell Lung Cancer Patients Treated With Tarceva After Failed Chemotherapy Treatment
Clinical trial update on Tarceva (erlotinib) in non-small cell lung cancer patients after failed chemotherapy; the study was terminated with…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer [Phase 2]
A Phase II clinical trial evaluating radiotherapy dose supplementation for hypoxic lesions in patients with Stage III non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2016-07-27Clinical Trial Update: Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer [Phase 2]
Phase II trial of bevacizumab with gemcitabine and carboplatin in newly diagnosed non-small cell lung cancer has completed and results poste…
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer [Phase 2]
Phase 2 trial evaluating 5-fluorouracil followed by interferon-alfa-2b in previously treated patients with metastatic gastrointestinal cance…
-
CLINICAL_TRIALS trial_result · 2016-07-25Clinical Trial Update: Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluated cisplatin/etoposide with radiotherapy followed by sorafenib consolidation in inoperable stage III non-small cell…
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: Intensity-modulated Radiotherapy (IMRT) With Simultaneous Integrated Boost (SIB) for Inoperable Non-small-cell Lung Cancer [Phase 2]
This document provides an update on a Phase 2 clinical trial evaluating intensity-modulated radiotherapy with simultaneous integrated boost …
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase Translocation
An update on the efficacy of crizotinib in patients with ALK-translocated non-small cell lung cancer.